Status:
COMPLETED
Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia
Lead Sponsor:
Nuon Therapeutics, Inc.
Conditions:
Gout
Hyperuricemia
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
This is a randomized, double-blind, 3-period crossover phase 2 study in patients with documented hyperuricemia to evaluate the effect of tranilast on febuxostat pharmacokinetics (PK) and pharmacodynam...
Eligibility Criteria
Inclusion
- Male or female, aged 18 to 70
- Subjects with hyperuricemia who are otherwise healthy
Exclusion
- Pregnant or nursing
- Known history of gout
- Clinically significant infection at Screening
- Known sensitivity to tranilast or febuxostat
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00995618
Start Date
September 1 2009
End Date
April 1 2010
Last Update
January 6 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Nuon Investigative Site
Honolulu, Hawaii, United States
2
Nuon Investigative Site
Evansville, Indiana, United States
3
Nuon Investigative Site
Dallas, Texas, United States